Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
Multidrug-Resistant Tuberculosis (MDR-TB) Disease Regardless of their occupation, patients known or likely to have pulmonary MDR-TB may be considered for return to work or school only if they meet all four of the criteria in Table 12. Table 12: RETURN TO WORK, SCHOOL, AND OTHER SETTINGS OF MULTIDRUG- RESISTANT CASES OF TUBERCULOSIS Criteria for Return to Work, School, or Other Social Settings: Patients with Suspected or Confirmed Multidrug-Resistant TB The resolution of fever and the resolution, or near resolution, of cough has occurred AND The patient is on current treatment with an antituberculosis regimen to which the strain is known or likely to be susceptible for at least 2 weeks AND The patient has had 3 consecutive negative acid-fast bacilli (AFB) sputum smear results collected 8 to 24 hours apart, with at least 1 being an early morning specimen AND The patient has had a negative culture for Mycobacterium tuberculosis *In addition, directly observed therapy (DOT) should be strongly encouraged for patients with MDR-TB. A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L INFECTION CONTROL 17.28 Revised November 2012
Tuberculosis Infection Control in Patient Care Facilities Patients with suspected tuberculosis (TB) may present for care in many different settings. The Centers for Disease Control and Prevention (CDC) has written a comprehensive set of guidelines for TB infection control in acute care hospitals and other medical settings. 50 In addition to the CDC guidelines, various professional organizations or state regulations may have guidelines for managing TB patients. The main focus in establishing a TB infection control program at a patient care facility is to: 1. assign responsibility for managing the program to a designated staff position; 2. perform and establish a TB risk assessment for the facility; and 3. develop the TB infection control plan based on the level of TB risk identified in the assessment. The main purpose for having an effective TB infection control plan in a facility is to assure that the activities necessary for TB control are addressed and that policies and procedures are developed to protect the healthcare workers, other patients, and visitors in the facility. Table 13: Guidelines for Tuberculosis Infection Control lists references that provide the information needed to conduct a TB risk assessment and write a TB infection control plan to establish policies and procedures for TB control activities inpatient care facilities. A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L INFECTION CONTROL 17.29 Revised November 2012 Call the Alaska TB Program at 907-269-8000 if you have any questions when consulting with institutions on infection control measures.
- Page 337 and 338: Education Topics During the initial
- Page 339 and 340: 10. Explain the signs and symptoms
- Page 341 and 342: Patient Education Materials Get th
- Page 343 and 344: References 1 CDC. Module 4: treatme
- Page 345 and 346: Introduction Purpose Use this secti
- Page 347 and 348: National Guidelines The following g
- Page 349 and 350: Transfer Notifications CONTENTS Int
- Page 351 and 352: For roles and responsibilities, ref
- Page 353 and 354: Follow-Up Type When to Initiate Not
- Page 355 and 356: Action Transfers Within Alaska Tran
- Page 357 and 358: Provide the patient with a. A copy
- Page 359 and 360: References 1 CDC. International not
- Page 361 and 362: Infection Control CONTENTS Introduc
- Page 363 and 364: of TB infection control principles
- Page 365 and 366: Administrative Activities 13 Key ac
- Page 367 and 368: Personal Respiratory Protection Alt
- Page 369 and 370: For regulations in your area, refer
- Page 371 and 372: Employee Health All employees, phys
- Page 373 and 374: Figure 1: TWO STEP TESTING AND FOLL
- Page 375 and 376: Isolation To reduce disease transmi
- Page 377 and 378: Table 4: CRITERIA FOR PATIENTS TO B
- Page 379 and 380: When to Initiate Airborne Infection
- Page 381 and 382: Confirmed Tuberculosis Disease A pa
- Page 383 and 384: Multidrug-Resistant Tuberculosis Di
- Page 385 and 386: Environmental Controls in the Patie
- Page 387: Return to Work, School, or Other So
- Page 391 and 392: Transportation Vehicles To prevent
- Page 393 and 394: 7 CDC. Guidelines for preventing th
- Page 395 and 396: Forms: Alaska State Public Health L
- Page 397 and 398: ALASKA STATE PUBLIC HEALTH LABORATO
- Page 399 and 400: Anchorage Alaska State Public Healt
- Page 401 and 402: INDEX CASE INFORMATION Name: DOB: /
- Page 403 and 404: CONTACT Name: Tuberculosis Contact
- Page 405 and 406: Directly Observed Therapy (DOT) Cal
- Page 407 and 408: B. Documents patient care activitie
- Page 409 and 410: Alaska TB Program Section of Epidem
- Page 411 and 412: Treatment Summary for Active TB Nam
- Page 413 and 414: Interjurisdictional Tuberculosis No
- Page 415 and 416: ! !"#$%&'%()*(+#(,"-./0'1$%+'.,)()/
- Page 417 and 418: ! B!9:(78;7)3702D!! ! 3"#$%&%''98#5
- Page 419 and 420: ! ?"#51)09/02!H0/.!9:(78;7)37028!/'
- Page 421 and 422: Latent Tuberculosis Infection (LTBI
- Page 423 and 424: Alaska Tuberculosis Program 9210 Va
- Page 425 and 426: Instructions for Collecting Sputum
- Page 427 and 428: TB Case Management Information Requ
- Page 429 and 430: Table 1: First-line anti-tuberculos
- Page 431 and 432: Return the fax to the Drug Room (90
- Page 433 and 434: Stock Orders: A small supply of
- Page 435 and 436: TB/LTBI Medication Return Form Reas
- Page 437 and 438: TB/LTBI Stock Medication Request FA
Multidrug-Resistant <strong>Tuberculosis</strong> (MDR-TB) Disease<br />
Regardless <strong>of</strong> their occupation, patients known or likely to have pulmonary MDR-TB may<br />
be considered for return to work or school only if they meet all four <strong>of</strong> the criteria in Table<br />
12.<br />
Table 12: RETURN TO WORK, SCHOOL, AND OTHER SETTINGS OF MULTIDRUG-<br />
RESISTANT CASES OF TUBERCULOSIS<br />
Criteria for Return to Work, School, or Other Social Settings:<br />
Patients with Suspected or Confirmed Multidrug-Resistant TB<br />
The resolution <strong>of</strong> fever and the resolution, or near resolution, <strong>of</strong> cough has occurred<br />
AND<br />
The patient is on current treatment with an antituberculosis regimen to which the strain is known or likely to be<br />
susceptible for at least 2 weeks<br />
AND<br />
The patient has had 3 consecutive negative acid-fast bacilli (AFB) sputum smear results collected 8 to 24 hours<br />
apart, with at least 1 being an early morning specimen<br />
AND<br />
The patient has had a negative culture for Mycobacterium tuberculosis<br />
*In addition, directly observed therapy (DOT) should be strongly encouraged for patients with MDR-TB.<br />
A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L INFECTION CONTROL 17.28<br />
Revised November 2012
Change language